Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | CD19CAR(2G)-T2A-HER2tG + EGFR806CAR(2G)-EGFRt |
Synonyms | |
Therapy Description |
Limited information is currently available on CD19CAR(2G)-T2A-HER2tG (Feb, 2019). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CD19CAR(2G)-T2A-HER2tG | Limited information is currently available on CD19CAR(2G)-T2A-HER2tG (Apr 2023). | |||
EGFR806CAR(2G)-EGFRt | EGFR Immune Cell Therapy 3 | Limited information is currently available on EGFR806CAR(2G)-EGFRt (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03618381 | Phase I | EGFR806CAR(2G)-EGFRt CD19CAR(2G)-T2A-HER2tG + EGFR806CAR(2G)-EGFRt | EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults | Recruiting | USA | 0 |